Ignite Creation Date:
2025-12-24 @ 4:38 PM
Ignite Modification Date:
2026-01-17 @ 6:31 AM
Study NCT ID:
NCT01763866
Status:
COMPLETED
Last Update Posted:
2022-11-08
First Post:
2013-01-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-01-15
Start Date Type:
ACTUAL
Primary Completion Date:
2013-11-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-12-04
Completion Date Type:
ACTUAL
First Submit Date:
2013-01-07
First Submit QC Date:
None
Study First Post Date:
2013-01-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-09-01
Results First Submit QC Date:
None
Results First Post Date:
2015-12-22
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-05-20
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2022-11-04
Last Update Post Date:
2022-11-08
Last Update Post Date Type:
ACTUAL